Diabetes Mellitus, Type 2  >>  Symlin (pramlintide)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Symlin (pramlintide) / AstraZeneca
NCT00108004: Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus

Completed
3b
400
US
pramlintide acetate
AstraZeneca
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
06/05
06/05

Download Options